234 related articles for article (PubMed ID: 7012048)
1. When and how to use sulfones in bullous diseases.
Jablonska S; Chorzelski T
Int J Dermatol; 1981 Mar; 20(2):103-5. PubMed ID: 7012048
[No Abstract] [Full Text] [Related]
2. The autoimmune bullous diseases.
Wakelin SH; Black MM
J R Coll Physicians Lond; 1997; 31(4):364-8. PubMed ID: 9263961
[No Abstract] [Full Text] [Related]
3. The blistering diseases.
Scott JE; Ahmed AR
Med Clin North Am; 1998 Nov; 82(6):1239-83. PubMed ID: 9889748
[TBL] [Abstract][Full Text] [Related]
4. Bullous diseases of childhood.
Gellis SE
Dermatol Clin; 1986 Jan; 4(1):89-98. PubMed ID: 3521982
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic experience in pemphigus and pemphigoid].
Aloi FG; Pippione M
G Ital Dermatol Venereol; 1984; 119(5):357-64. PubMed ID: 6392076
[No Abstract] [Full Text] [Related]
6. Mixed bullous disease.
Barranco VP
Arch Dermatol; 1974 Aug; 110(2):221-4. PubMed ID: 4604780
[No Abstract] [Full Text] [Related]
7. Dapsone for the treatment of vesiculo-bullous and pustular diseases.
Piamphongsant T
Int J Dermatol; 1982 Nov; 21(9):512. PubMed ID: 6218127
[No Abstract] [Full Text] [Related]
8. [Childhood benign chronic bullous dermatosis. Differential diagnosis with dermatitis herpetiformis and bullous pemphigoid].
Casanova JM; Vives P; Hernanz JM; Cimadevilla JC; González CM
An Esp Pediatr; 1985 Jan; 22(1):37-42. PubMed ID: 3885812
[TBL] [Abstract][Full Text] [Related]
9. Three blistering diseases. Why proper management is critical.
Wooldridge WE
Postgrad Med; 1990 Sep; 88(3):103-4, 106. PubMed ID: 2204894
[TBL] [Abstract][Full Text] [Related]
10. Immunofluorescence tests. Clinical significance of sera and skin in bullous diseases.
Beutner EH; Chorzelski TP; Jablonska S
Int J Dermatol; 1985 Sep; 24(7):405-21. PubMed ID: 3902680
[No Abstract] [Full Text] [Related]
11. Immunoelectron microscopy--how useful is it for the dermatologist?
Holubar K
Br J Dermatol; 1984 Apr; 110(4):499-503. PubMed ID: 6370295
[No Abstract] [Full Text] [Related]
12. Blistering disorders: diagnosis and treatment.
Yeh SW; Ahmed B; Sami N; Razzaque Ahmed A
Dermatol Ther; 2003; 16(3):214-23. PubMed ID: 14510878
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune bullous skin disorders].
Hertl M; Niedermeier A; Borradori L
Ther Umsch; 2010 Sep; 67(9):465-82. PubMed ID: 20806175
[TBL] [Abstract][Full Text] [Related]
14. Dapsone--other indications.
Barranco VP
Int J Dermatol; 1982 Nov; 21(9):513-4. PubMed ID: 6218128
[No Abstract] [Full Text] [Related]
15. [Autoimmune blistering skin diseases: diagnostic and therapeutic approach].
Hammers CM; Schmidt E; Zillikens D
Dtsch Med Wochenschr; 2014 Jul; 139(28-29):1473-7. PubMed ID: 24983196
[No Abstract] [Full Text] [Related]
16. [Clinical characteristics of herpetiform dermatitis and bullous pemphigoid].
Sheklakova MN
Vestn Dermatol Venerol; 1980 Nov; (11):39-41. PubMed ID: 7003978
[No Abstract] [Full Text] [Related]
17. Chronic bullous dermatosis of childhood.
Tomecki KJ
South Med J; 1983 May; 76(5):651-3. PubMed ID: 6342155
[TBL] [Abstract][Full Text] [Related]
18. Bullous diseases: Kids are not just little people.
Marathe K; Lu J; Morel KD
Clin Dermatol; 2015; 33(6):644-56. PubMed ID: 26686016
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
Sollfrank L; Schönfelder V; Sticherling M
Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
[TBL] [Abstract][Full Text] [Related]
20. Dermatitis herpetiformis and bullous pemphigoid. Intermediate and mixed forms.
Jablonska S; Chorzelski TP; Beutner EH; Maciejowska E; Rzesa G
Arch Dermatol; 1976 Jan; 112(1):45-8. PubMed ID: 1108803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
